Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

717 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).
Cannon CP, Rhee KE, Califf RM, Boden WE, Hirsch AT, Alberts MJ, Cable G, Shao M, Ohman EM, Steg PG, Eagle KA, Bhatt DL; REACH Registry Investigators. Cannon CP, et al. Among authors: eagle ka. Am J Cardiol. 2010 Feb 15;105(4):445-52. doi: 10.1016/j.amjcard.2009.10.014. Epub 2010 Jan 5. Am J Cardiol. 2010. PMID: 20152237
Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
Kumar A, Fonarow GC, Eagle KA, Hirsch AT, Califf RM, Alberts MJ, Boden WE, Steg PG, Shao M, Bhatt DL, Cannon CP; REACH Investigators. Kumar A, et al. Among authors: eagle ka. Crit Pathw Cardiol. 2009 Sep;8(3):104-11. doi: 10.1097/HPC.0b013e3181b8395d. Crit Pathw Cardiol. 2009. PMID: 19726929
Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) registry.
Meadows TA, Bhatt DL, Hirsch AT, Creager MA, Califf RM, Ohman EM, Cannon CP, Eagle KA, Alberts MJ, Goto S, Smith SC Jr, Wilson PW, Watson KE, Steg PG; REACH Registry Investigators. Meadows TA, et al. Among authors: eagle ka. Am Heart J. 2009 Dec;158(6):1038-45. doi: 10.1016/j.ahj.2009.09.014. Am Heart J. 2009. PMID: 19958873
Prior cardiovascular interventions are not associated with worsened clinical outcomes in patients with symptomatic atherothrombosis.
Boden WE, Cherr GS, Eagle KA, Cannon CP, Califf RM, Hirsch AT, Alberts MJ, Criqui M, Creager MA, Massaro JM, D'Agostino RB Sr, Steg PG, Bhatt DL; REACH Registry Investigators. Boden WE, et al. Among authors: eagle ka. Crit Pathw Cardiol. 2010 Sep;9(3):116-25. doi: 10.1097/HPC.0b013e3181e7f93e. Crit Pathw Cardiol. 2010. PMID: 20802264
Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH Registry.
Rodriguez F, Cannon CP, Steg PG, Kumbhani DJ, Goto S, Smith SC, Eagle KA, Ohman EM, Umez-Eronini AA, Hoffman E, Bhatt DL; REACH Registry Investigators. Rodriguez F, et al. Among authors: eagle ka. Clin Cardiol. 2013 Dec;36(12):721-7. doi: 10.1002/clc.22217. Epub 2013 Oct 25. Clin Cardiol. 2013. PMID: 24166484 Free PMC article.
Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry.
Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SC Jr, Goto S, Ohman EM, Elbez Y, Sritara P, Baumgartner I, Banerjee S, Creager MA, Bhatt DL; REACH Registry Investigators. Kumbhani DJ, et al. Among authors: eagle ka. Eur Heart J. 2014 Nov 1;35(41):2864-72. doi: 10.1093/eurheartj/ehu080. Epub 2014 Feb 28. Eur Heart J. 2014. PMID: 24585266 Free PMC article.
717 results